Insider · CIK 0001830328

Adcock Richard

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001830328

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-22	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−152K sh	—	—	152,439
2026-02-22	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−77.6K sh	$8.70	−$675K	560,344
2026-02-22	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+152K sh	—	—	637,904
2026-02-10	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+274K sh	—	—	625,513
2026-02-10	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−274K sh	—	—	548,246
2026-02-10	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−140K sh	$6.93	−$971K	485,465
2025-12-31	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−17.5K sh	$1.98	−$34.7K	351,391
2025-12-31	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−34.5K sh	—	—	51,731
2025-12-31	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+34.5K sh	—	—	368,901
2025-02-22	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−78.2K sh	$3.42	−$267K	334,418
2025-02-22	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−152K sh	—	—	304,878
2025-02-22	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+152K sh	—	—	412,585
2025-02-10	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+2.81M sh	—	—	2,812,500
2025-02-10	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Director, CEO & President	AAward	+822K sh	—	—	822,368
2024-12-31	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−17.5K sh	$2.56	−$44.7K	260,146
2024-12-31	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+34.5K sh	—	—	277,621
2024-12-31	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−34.5K sh	—	—	86,214
2024-02-22	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+1.59M sh	—	—	1,591,463
2024-02-22	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Director, CEO & President	AAward	+457K sh	—	—	457,317
2024-02-05	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−43.2K sh	$4.04	−$174K	243,138
2024-02-05	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+83.3K sh	—	—	286,303
2024-02-05	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−83.3K sh	—	—	0
2023-12-31	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−17.1K sh	$5.02	−$85.8K	202,969
2023-12-31	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−34.5K sh	—	—	120,697
2023-12-31	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+34.5K sh	—	—	220,065
2023-02-05	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+83.3K sh	—	—	227,774
2023-02-05	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−83.3K sh	—	—	83,334
2023-02-05	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−42.2K sh	$4.33	−$183K	185,582
2022-12-31	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−8,620 sh	—	—	155,180
2022-12-31	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+8,620 sh	—	—	148,714
2022-12-31	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−4,273 sh	$5.07	−$21.7K	144,441
2022-03-23	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+350K sh	—	—	350,000
2022-03-23	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+350K sh	—	—	350,000
2022-02-05	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−83.3K sh	—	—	166,667
2022-02-05	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−29.4K sh	$5.39	−$159K	140,094
2022-02-05	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+83.3K sh	—	—	169,509
2021-10-08	IBRXImmunityBio, Inc.P Purchase	Director, CEO & President	PPurchase	+7 sh	$9.00	+$63	7
2021-10-08	IBRXImmunityBio, Inc.P Purchase	Director, CEO & President	PPurchase	+1,923 sh	$8.80	+$16.9K	1,930
2021-09-09	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−8,620 sh	—	—	163,800
2021-09-09	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−4,273 sh	$9.95	−$42.5K	86,176
2021-09-09	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+8,620 sh	—	—	90,449
2021-03-09	IBRXImmunityBio, Inc. · Restricted Stock UnitsJ Other	Director, CEO & President	JOther	+172K sh	—	—	172,420
2021-02-05	IBRXImmunityBio, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+150K sh	—	—	150,000
2021-02-05	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+750K sh	—	—	750,000
2021-02-05	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Director, CEO & President	AAward	+250K sh	—	—	250,000
2021-02-05	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Director, CEO & President	AAward	+150K sh	—	—	150,000
2021-02-05	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−150K sh	—	—	0
2021-02-05	IBRXImmunityBio, Inc.F Tax Payment	Director, CEO & President	FTax Payment	−68.2K sh	$23.72	−$1.62M	81,829

Recent filings

Accepted (ET)
Feb 244
Adcock Richard0001830328-26-000005
SEC(opens sec.gov)
Feb 124
Adcock Richard0001830328-26-000003
SEC(opens sec.gov)
Jan 54
Adcock Richard0001830328-26-000001
SEC(opens sec.gov)
Feb 254
Adcock Richard0001326110-25-000021
SEC(opens sec.gov)
Feb 124
Adcock Richard0001326110-25-000011
SEC(opens sec.gov)
Jan 34
Adcock Richard0001326110-25-000004
SEC(opens sec.gov)
Feb 264
Adcock Richard0001326110-24-000025
SEC(opens sec.gov)
Feb 64
Adcock Richard0001326110-24-000018
SEC(opens sec.gov)

Companies

ImmunityBio, Inc.Director, CEO & PresidentIBRX

Address

C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121